AbbVie: all 2,241 studies

Page 9 of 23. Open to participants first (134), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination StudyCompletedNCT01609933Phase 2Results posted
• First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid TumorsCompletedNCT01609556Phase 1Results posted
• Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®CompletedNCT01608672Results posted
• An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type ACompletedNCT01608659Results posted
• A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract SurgeryTerminatedNCT01605942Phase 1Results posted
• BOTOX® Open-Label Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603641Phase 3Results posted
• BOTOX® Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603628Phase 3Results posted
• BOTOX® Open-Label Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603615Phase 3Results posted
• BOTOX® Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603602Phase 3Results posted
• Reliability of the Facial Wrinkle Scale in Japanese SubjectsCompletedNCT01600729Results posted
• Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)CompletedNCT01600716Phase 3Results posted
• Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body CurvatureCompletedNCT01600638Not applicableResults posted
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)CompletedNCT01594970Phase 4Results posted
• An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)CompletedNCT01592786Phase 2Results posted
• Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)TerminatedNCT01592773Phase 2Results posted
• Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With MemantineCompletedNCT01592747Phase 2Results posted
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01589510Results posted
• Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume EnhancementCompletedNCT01579305Not applicableResults posted
• Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With RosaceaCompletedNCT01579084Phase 1Results posted
• A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01578707Phase 3Results posted
• BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb SpasticityCompletedNCT01575054Phase 3Results posted
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01571557Results posted
• Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedNCT01568021Results posted
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01568008Results posted
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionCompletedNCT01566526Results posted
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected SubjectsCompletedNCT01563536Phase 2Results posted
• Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.CompletedNCT01561313Phase 2Results posted
• The Volumizing Effect of Juvéderm VOLUMA® in the Mid-FaceCompletedNCT01559064Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553747Phase 3Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553591Phase 3Results posted
• A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice SettingCompletedNCT01550965Phase 3Results posted
• Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) ReductionCompletedNCT01547598Phase 4Results posted
• Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental AreaCompletedNCT01546142Phase 3Results posted
• Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental AreaCompletedNCT01542034Phase 3Results posted
• Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)CompletedNCT01540370Results posted
• Surveillance of Synagis in Korean Pediatric PatientsCompletedNCT01537198Results posted
• Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary HypogonadismCompletedNCT01534208Phase 3Results posted
• Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary HypogonadismCompletedNCT01532414Phase 3Results posted
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionCompletedNCT01525173Phase 4Results posted
• Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy WomenCompletedNCT01518270Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee PainCompletedNCT01518257Phase 1/2Results posted
• Non-Invasive Reduction of Fat in the Inner ThighsCompletedNCT01517659Not applicableResults posted
• A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic MigraineCompletedNCT01516892Phase 4Results posted
• A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCompletedNCT01506947Phase 4Results posted
• Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerCompletedNCT01506609Phase 2Results posted
• A Crossover Study of the Safety and Tolerability of Two Formulations of AdalimumabCompletedNCT01502423Phase 2Results posted
• Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular EdemaCompletedNCT01492400Phase 2Results posted
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01489670Results posted
• Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's DiseaseCompletedNCT01479127Phase 2Results posted
• Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple MyelomaCompletedNCT01478581Phase 2Results posted
• Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial CystitisTerminatedNCT01475253Phase 2Results posted
• Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisCompletedNCT01474876Results posted
• Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive DisorderCompletedNCT01473394Phase 4Results posted
• Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01473381Phase 4Results posted
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic ConjunctivitisCompletedNCT01470118Phase 4Results posted
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive DisorderCompletedNCT01469377Phase 2Results posted
• Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With KetoconazoleCompletedNCT01468558Phase 1Results posted
• Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01468233Phase 3Results posted
• Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaCompletedNCT01468207Phase 3Results posted
• Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsCompletedNCT01466062Phase 3Results posted
• ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsCompletedNCT01464827Phase 2Results posted
• Special Investigation (Long-term Investigation) in Patients With Crohn's DiseaseCompletedNCT01464333Results posted
• A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in ChinaTerminatedNCT01464021Results posted
• Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye DiseaseCompletedNCT01459588Phase 3Results posted
• A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)CompletedNCT01458535Phase 2Results posted
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)CompletedNCT01455597Phase 3Results posted
• Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine FibroidsCompletedNCT01451424Phase 2Results posted
• Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash ProminenceCompletedNCT01448525Phase 4Results posted
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)CompletedNCT01445626Results posted
• Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine FibroidsCompletedNCT01441635Phase 2Results posted
• BOTOX® Prophylaxis in Patients With Chronic MigraineCompletedNCT01432379Results posted
• Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01431339Phase 3Results posted
• Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving AdalimumabCompletedNCT01428115Results posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted
• Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental AreaCompletedNCT01426373Phase 3Results posted
• A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With GlaucomaTerminatedNCT01426113Phase 3Results posted
• Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)CompletedNCT01415531Phase 4Results posted
• Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment ScaleCompletedNCT01412086Results posted
• A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaCompletedNCT01412060Phase 3Results posted
• Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic ArthritisCompletedNCT01412021Results posted
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)CompletedNCT01411696Results posted
• Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian FederationCompletedNCT01401478Results posted
• Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbiditiesCompletedNCT01401452Results posted
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal WomenCompletedNCT01400776Phase 3Results posted
• Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)CompletedNCT01397409Phase 2Results posted
• Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar DepressionCompletedNCT01396447Phase 2Results posted
• Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown LinesCompletedNCT01391312Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown LinesCompletedNCT01391299Not applicableResults posted
• Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash HypotrichosisCompletedNCT01391286Phase 3Results posted
• Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash HypotrichosisCompletedNCT01391273Phase 3Results posted
• Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in PsoriasisCompletedNCT01387815Results posted
• A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in MalaysiaCompletedNCT01387789Results posted
• Observational Study of Botox® Treatment for Patients With Upper Limb Adult SpasticityCompletedNCT01387074Results posted
• Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational StudyCompletedNCT01386684Results posted
• The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)CompletedNCT01386606Phase 2Results posted
• Retrospective Study of Patients With Spasticity in the Spanish PopulationCompletedNCT01383681Results posted
• Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)CompletedNCT01383421Results posted
• Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)CompletedNCT01383005Results posted
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
• Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderCompletedNCT01377194Phase 3Results posted

← AbbVie overview and focus areas